# Hemodynamic Response to Exercise in HFpEF Patients After Upregulation of SERCA2a

> **NCT02772068** · EARLY_PHASE1 · COMPLETED · sponsor: **Benjamin Levine** · enrollment: 26 (actual)

## Conditions studied

- Heart Failure, Congestive

## Interventions

- **DRUG:** Istaroxime
- **OTHER:** Exercise

## Key facts

- **NCT ID:** NCT02772068
- **Lead sponsor:** Benjamin Levine
- **Sponsor class:** OTHER
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-09-15
- **Primary completion:** 2018-12-01
- **Final completion:** 2018-12-01
- **Target enrollment:** 26 (ACTUAL)
- **Last updated:** 2022-06-29

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02772068

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02772068, "Hemodynamic Response to Exercise in HFpEF Patients After Upregulation of SERCA2a". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT02772068. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*